IN230659B - - Google Patents

Info

Publication number
IN230659B
IN230659B IN1264CH2006A IN230659B IN 230659 B IN230659 B IN 230659B IN 1264CH2006 A IN1264CH2006 A IN 1264CH2006A IN 230659 B IN230659 B IN 230659B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Nobukazu Tanaka
Yoshiro Nagai
Hiroshi Kawaguchi
Tadashi Fukami
Terumasa Hosokawa
Original Assignee
Fuji Chem Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Chem Ind Co Ltd filed Critical Fuji Chem Ind Co Ltd
Publication of IN2006CH01264A publication Critical patent/IN2006CH01264A/en
Publication of IN230659B publication Critical patent/IN230659B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN1264CH2006 2003-10-15 2004-09-21 IN230659B (OSRAM)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003355076 2003-10-15
JP2004236573A JP3841804B2 (ja) 2003-10-15 2004-08-16 口腔内速崩壊性錠剤用の組成物

Publications (2)

Publication Number Publication Date
IN2006CH01264A IN2006CH01264A (OSRAM) 2007-06-29
IN230659B true IN230659B (OSRAM) 2009-03-27

Family

ID=34380419

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1264CH2006 IN230659B (OSRAM) 2003-10-15 2004-09-21

Country Status (7)

Country Link
US (1) US7838033B2 (OSRAM)
EP (1) EP1523974B1 (OSRAM)
JP (1) JP3841804B2 (OSRAM)
KR (1) KR101119850B1 (OSRAM)
ES (1) ES2694498T3 (OSRAM)
IN (1) IN230659B (OSRAM)
WO (1) WO2005037319A1 (OSRAM)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
US8349361B2 (en) * 2003-10-15 2013-01-08 Fuji Chemical Industry Co., Ltd. Composition for rapid disintegrating tablet in oral cavity
ES2688193T3 (es) * 2003-10-15 2018-10-31 Fuji Chemical Industry Co., Ltd. Comprimido de disgregación rápida en la cavidad oral
DE102005009240A1 (de) 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
IL169678A (en) 2005-07-14 2010-11-30 Innova Sa Sweetener compositions
KR20130016386A (ko) 2005-08-10 2013-02-14 시오노기세이야쿠가부시키가이샤 구강내 붕괴 정제
JP4965096B2 (ja) * 2005-08-19 2012-07-04 テバ製薬株式会社 圧縮成型製剤
WO2007029376A1 (ja) * 2005-09-02 2007-03-15 Fuji Chemical Industry Co., Ltd. 口腔内速崩壊性錠剤
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
JP5535616B2 (ja) 2006-03-31 2014-07-02 ルビコン リサーチ プライベート リミテッド 口腔内崩壊錠剤のための直接圧縮性複合材
HUE046441T2 (hu) * 2006-09-26 2020-02-28 Novartis Ag S1P modulátort tartalmazó gyógyászati készítmények
EP2101739A2 (en) * 2006-12-21 2009-09-23 Mallinckrodt Inc. Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients
WO2008079342A2 (en) * 2006-12-21 2008-07-03 Mallinckrodt Inc. Composition of and method for preparing orally disintegrating tablets
UY31411A1 (es) * 2007-10-30 2009-05-29 Composicion orodispersable sin mal olor o mal sabor que comprende acidos grasos poliinsaturados
EP2262487A2 (en) * 2008-02-29 2010-12-22 Otsuka Pharmaceutical Co., Ltd. An orally disintegrating tablet of cilostazol
JP5572321B2 (ja) * 2008-03-07 2014-08-13 沢井製薬株式会社 被覆微粒子含有口腔内崩壊錠
KR101046789B1 (ko) * 2008-07-16 2011-07-05 동아제약주식회사 안정성이 개선된 암로디핀 속붕해성 정제 및 그의 제조방법
US20100120776A1 (en) * 2008-11-12 2010-05-13 Hall Bioscience Corporation Carbocysteine medical foods
CA2744377A1 (en) * 2008-11-20 2010-05-27 Avantor Performance Materials, Inc. Directly compressible high functionality granular dibasic calcium phosphate based co-processed excipient
JP4329947B1 (ja) 2009-01-20 2009-09-09 ライオン株式会社 内服用錠剤
EP2397161B1 (en) * 2009-02-12 2019-09-25 Fuji Chemical Industry Co., Ltd. Disintegrating particle composition and rapidly disintegrating compression-molded material comprising same
WO2010104563A2 (en) * 2009-03-09 2010-09-16 Spi Pharma, Inc. Highly compactable and durable direct compression excipients and excipient systems
WO2010126828A1 (en) * 2009-04-28 2010-11-04 Isp Investments Inc. Co-processed excipient compositions
US20100285164A1 (en) * 2009-05-11 2010-11-11 Jrs Pharma Orally Disintegrating Excipient
JP5458096B2 (ja) 2009-05-20 2014-04-02 大日本住友製薬株式会社 有核型の口腔内崩壊錠
EP2440210A4 (en) * 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
JP5835875B2 (ja) * 2009-06-29 2015-12-24 富士化学工業株式会社 口腔内速崩壊錠の製造方法
JP5674666B2 (ja) * 2009-08-11 2015-02-25 富士化学工業株式会社 崩壊性粒子組成物及び口腔内速崩壊錠
EP2465540B1 (en) * 2009-08-11 2016-10-05 Fuji Chemical Industry Co., Ltd. Disintegrating particle composition and orally rapidly disintegrating tablet
JP4920798B2 (ja) 2009-08-11 2012-04-18 大日本住友製薬株式会社 ２種以上の粒子を含有する口腔内速崩壊錠
TWI461213B (zh) 2009-11-05 2014-11-21 Fmc Corp 作為藥物賦形劑之微晶纖維素及磷酸鈣之組合物
WO2012085043A2 (en) 2010-12-22 2012-06-28 Basf Se Rapidly disintegrating, solid coated dosage form
US8715729B2 (en) 2010-12-22 2014-05-06 Basf Se Rapidly disintegrating, solid coated dosage form
ES2694224T3 (es) * 2012-04-24 2018-12-19 Daiichi Sankyo Company, Limited Comprimido de desintegración oral y procedimiento para producir el mismo
EP2875830A4 (en) 2012-07-20 2016-02-24 Otsuka Pharma Co Ltd TABLET HAVING DRY INK FILM ON THE SURFACE THEREOF, AND INK FOR INKJET PRINTER
FR2999432B1 (fr) * 2012-12-17 2014-12-12 Ethypharm Sa Comprimes orodispersibles obtenus par compression moulage
US20160136091A1 (en) * 2013-07-19 2016-05-19 Sanwa Kagaku Kenkyusho Co., Ltd. Orally Disintegrating Tablet
JP2015063521A (ja) * 2013-09-02 2015-04-09 科研製薬株式会社 高い薬物含有率を有する錠剤及びその製造方法
WO2015053227A1 (ja) * 2013-10-07 2015-04-16 富士フイルム株式会社 口腔内崩壊錠
US10231476B2 (en) 2014-04-04 2019-03-19 Douxmatok Ltd Sweetener compositions and foods, beverages, and consumable products made thereof
US10207004B2 (en) 2014-04-04 2019-02-19 Douxmatok Ltd Method for producing sweetener compositions and sweetener compositions
US20160242439A1 (en) 2014-04-04 2016-08-25 Douxmatok Ltd Method for producing sweetener compositions and sweetener compositions
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
KR102662025B1 (ko) 2015-06-18 2024-05-02 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 에스테트롤 성분을 함유하는 구강분해성 투여 단위
WO2016203011A1 (en) 2015-06-18 2016-12-22 Mithra Pharmaceuticals S.A. Orodispersible dosage unit containing an estetrol component
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
CN110237261A (zh) * 2019-07-30 2019-09-17 珠海市东辰制药有限公司 一种复合崩解剂及其制备方法
CN110840855B (zh) * 2019-11-27 2022-04-12 哈尔滨珍宝制药有限公司 依托考昔片及其制备方法
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
WO2021214254A1 (en) * 2020-04-24 2021-10-28 Astrazeneca Ab Pharmaceutical formulations
JPWO2022210829A1 (OSRAM) * 2021-04-01 2022-10-06

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US75437A (en) * 1868-03-10 Improvement in steaw-cutters
JP3069458B2 (ja) 1992-01-29 2000-07-24 武田薬品工業株式会社 口腔内崩壊型錠剤およびその製造法
DE59400446D1 (de) * 1993-04-15 1996-08-29 Gergely Gerhard Brausesystem mit einem alkali- und/oder metallempfindlichen, pharmazeutischen Wirkstoff, und Verfahren zur Herstellung
IL110376A (en) * 1993-08-02 1998-08-16 Bristol Myers Squibb Co Pharmaceutical compositions containing ifetroban salts and methods for the preparation thereof
TW391880B (en) 1994-01-31 2000-06-01 Yamanouchi Pharma Co Ltd An oral soluble type compression moulding and its preparation
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
ATE352289T1 (de) 1995-05-02 2007-02-15 Taisho Pharmaceutical Co Ltd Mittel zur oralen verabreichung
JP2003176242A (ja) 1996-07-12 2003-06-24 Dai Ichi Seiyaku Co Ltd 速崩壊性圧縮成型物及びその製造法
JP3961596B2 (ja) 1996-10-15 2007-08-22 富士化学工業株式会社 無機制酸剤含有速分散性造粒物、その製造方法及び用時懸濁内服制酸剤
JPH11302157A (ja) * 1998-04-17 1999-11-02 Eisai Co Ltd 口腔内速崩壊性錠剤
JP4711470B2 (ja) 1998-04-24 2011-06-29 富士化学工業株式会社 崩壊補助剤、崩壊補助剤含有口腔内即（速）溶剤用組成物及び口腔内即（速）溶剤の製造方法
US20010023252A1 (en) * 1998-07-02 2001-09-20 Smithkline Beecham Plc Novel compound
JP2000086537A (ja) 1998-09-11 2000-03-28 Fuji Chem Ind Co Ltd 無機化合物糖類組成物、賦形剤、速崩壊性圧縮成型物及びその製造方法
US7815937B2 (en) 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
FR2785538B1 (fr) * 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
AU3574500A (en) 1999-03-25 2000-10-16 Yuhan Corporation Rapidly disintegrable tablet for oral administration
KR20010006835A (ko) * 1999-03-25 2001-01-26 김선진 경구용 속붕해정
CA2374760A1 (en) * 1999-06-18 2000-12-28 Takeda Chemical Industries, Ltd. Quickly disintegrating solid preparations
JP4588818B2 (ja) * 1999-09-16 2010-12-01 日本化学機械製造株式会社 錠剤用賦形剤及び錠剤
WO2003030868A1 (en) 2001-10-09 2003-04-17 Bristol-Myers Squibb Company Flashmelt oral dosage formulation
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
US6316029B1 (en) 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
JP2002128661A (ja) * 2000-10-20 2002-05-09 Chugai Pharmaceut Co Ltd 速崩壊錠剤の製造方法
JP2002154948A (ja) 2000-11-22 2002-05-28 Eisai Co Ltd 崩壊性に優れた錠剤
CA2440361A1 (en) 2001-03-06 2002-09-12 Kyowa Hakko Kogyo Co. Ltd. Intraorally rapidly disintegrable preparation
AR034757A1 (es) 2001-07-16 2004-03-17 Astrazeneca Ab Formulacion farmaceutica que comprende un inhibidor de bomba de protones y antiacidos
US7118765B2 (en) 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
AU2003221326A1 (en) * 2002-03-06 2003-09-16 Kyowa Hakko Kogyo Co., Ltd. Tablets quickly disintegrating in oral cavity

Also Published As

Publication number Publication date
EP1523974B1 (en) 2018-08-08
KR101119850B1 (ko) 2012-02-28
US7838033B2 (en) 2010-11-23
WO2005037319A1 (ja) 2005-04-28
KR20070018777A (ko) 2007-02-14
JP3841804B2 (ja) 2006-11-08
US20050106240A1 (en) 2005-05-19
EP1523974A1 (en) 2005-04-20
JP2005139168A (ja) 2005-06-02
IN2006CH01264A (OSRAM) 2007-06-29
ES2694498T3 (es) 2018-12-21

Similar Documents

Publication Publication Date Title
BE2014C055I2 (OSRAM)
BE2013C075I2 (OSRAM)
BE2013C070I2 (OSRAM)
BE2013C067I2 (OSRAM)
BE2013C038I2 (OSRAM)
BE2013C036I2 (OSRAM)
JP2003320827A5 (OSRAM)
BE2011C030I2 (OSRAM)
IN2009CH00167A (OSRAM)
JP2004046858A5 (OSRAM)
JP2004006753A5 (OSRAM)
IN2006CH01264A (OSRAM)
JP2003256726A5 (OSRAM)
BE2013C034I2 (OSRAM)
JP2003304233A5 (OSRAM)
JP2004054935A5 (OSRAM)
BE2012C053I2 (OSRAM)
JP2003289502A5 (OSRAM)
JP2003331904A5 (OSRAM)
IN2005KO01768A (OSRAM)
JP2003212293A5 (OSRAM)
AU2002341898A1 (OSRAM)
AU2002239060A1 (OSRAM)
AU2002353888A1 (OSRAM)
AU2002254171A1 (OSRAM)